Rate My Professor Derek Gilroy

Professor Derek Gilroy is a leading academic in the field of experimental inflammation at University College London. He serves as Professor of Experimental Inflammation and Head of the Department of Experimental and Translational Medicine within the Faculty of Medical Sciences, Division of Medicine. His research focuses on the mechanisms of inflammation and its resolution, with particular emphasis on pro-resolution pathways and their potential to address chronic inflammatory diseases.

Professor Gilroy obtained his PhD in 1997 from the William Harvey Research Institute at the University of London. He joined University College London and was appointed Professor of Experimental Immunology in 2010. In addition to his academic roles, he is the founder and CEO of Penta Therapeutics. His work has contributed to advancing understanding of inflammatory processes and therapeutic approaches in immunology and experimental medicine.